Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Autoimmune Diseases Working Party (ADWP)

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Kirill Kirgizov

Fecal transplant FOR GVHD

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Dr. J. Bilinski

Complications of CTX-based haploidentical stem cell transplantation – prospective observational study

Non-interventional Prospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Incidence and outcome of pregnancy following stem cell transplantation

Retrospective Studies

Complications: non-infectious

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients

Clinical Trials Phase I-III

Complications: infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal